OBJECTIVE: Patients referred for implantable continuous-flow left ventricular assist devices (cfLVAD) frequently have preoperative right heart failure and tricuspid regurgitation (TR). The objective of this report is to examine early clinical benefits of concomitant tricuspid surgery for these patients. METHODS: Sixty-one of 200 consecutive cfLVAD patients at our institution displayed preimplant right heart dysfunction and significant TR. Thirty-three underwent cfLVAD plus a tricuspid valve procedure (TVP), and 28 had cfLVAD alone. Preimplant characteristics and clinical outcomes were retrospectively studied. As previously described, post-LVAD right ventricular failure was defined as need for right ventricular assist device (RVAD) support or greater than 14 days of intravenous inotropic support. RESULTS: Preimplant characteristics were similar between the 2 groups. Cardiopulmonary bypass time was increased for the group that received concomitant TVPs. The most common TVP consisted of an undersizing ring annuloplasty. The cfLVAD-alone group had greater TR after implant relative to the cfLVAD+TVP group. The cfLVAD-alone group experienced greater postprocedure right ventricular failure relative to cfLVAD+TVP (46.4% vs 18.2%; P < .05). Furthermore, prolonged hospitalization was increased for the cfLVAD-alone group versus the cfLVAD+TVP. Survival was similar between the 2 groups. CONCLUSIONS: Concomitant TVP appears to reduce postprocedure right ventricular failure for patients with significant TR undergoing cfLVAD implantation.
OBJECTIVE:Patients referred for implantable continuous-flow left ventricular assist devices (cfLVAD) frequently have preoperative right heart failure and tricuspid regurgitation (TR). The objective of this report is to examine early clinical benefits of concomitant tricuspid surgery for these patients. METHODS: Sixty-one of 200 consecutive cfLVADpatients at our institution displayed preimplant right heart dysfunction and significant TR. Thirty-three underwent cfLVAD plus a tricuspid valve procedure (TVP), and 28 had cfLVAD alone. Preimplant characteristics and clinical outcomes were retrospectively studied. As previously described, post-LVAD right ventricular failure was defined as need for right ventricular assist device (RVAD) support or greater than 14 days of intravenous inotropic support. RESULTS: Preimplant characteristics were similar between the 2 groups. Cardiopulmonary bypass time was increased for the group that received concomitant TVPs. The most common TVP consisted of an undersizing ring annuloplasty. The cfLVAD-alone group had greater TR after implant relative to the cfLVAD+TVP group. The cfLVAD-alone group experienced greater postprocedure right ventricular failure relative to cfLVAD+TVP (46.4% vs 18.2%; P < .05). Furthermore, prolonged hospitalization was increased for the cfLVAD-alone group versus the cfLVAD+TVP. Survival was similar between the 2 groups. CONCLUSIONS: Concomitant TVP appears to reduce postprocedure right ventricular failure for patients with significant TR undergoing cfLVAD implantation.
Authors: Antolin S Flores; Michael Essandoh; Gregory C Yerington; Amar M Bhatt; Manoj H Iyer; William Perez; Victor R Davila; Ravi S Tripathi; Katja Turner; Galina Dimitrova; Michael J Andritsos Journal: J Thorac Dis Date: 2015-12 Impact factor: 2.895
Authors: Pavan Atluri; Alexander S Fairman; John W MacArthur; Andrew B Goldstone; Jeffrey E Cohen; Jessica L Howard; Christyna M Zalewski; Yasuhiro Shudo; Y Joseph Woo Journal: J Card Surg Date: 2013-09-30 Impact factor: 1.620
Authors: Robert J Brewer; Rafael Cabrera; Mazen El-Atrache; Amna Zafar; Tara N Hrobowski; Hassan M Nemeh; Yelena Selektor; Gaetano Paone; Celeste T Williams; Mauricio Velez; Cristina Tita; Jeffrey A Morgan; David E Lanfear Journal: Int J Artif Organs Date: 2014-11-29 Impact factor: 1.595
Authors: Howard K Song; Jill M Gelow; James Mudd; Christopher Chien; Frederick A Tibayan; Kathryn Hollifield; David Naftel; James Kirklin Journal: Ann Thorac Surg Date: 2016-04-30 Impact factor: 4.330
Authors: Yaron D Barac; Alina Nicoara; Muath Bishawi; Jacob N Schroder; Mani A Daneshmand; Nazish K Hashmi; Eric Velazquez; Joseph G Rogers; Chetan B Patel; Carmelo A Milano Journal: JACC Heart Fail Date: 2019-12-11 Impact factor: 12.035
Authors: Salim Hayek; Daniel B Sims; David W Markham; Javed Butler; Andreas P Kalogeropoulos Journal: Circ Cardiovasc Imaging Date: 2014-03 Impact factor: 7.792
Authors: Konstantin Zhigalov; Marcin Szczechowicz; Ahmed Mashhour; Bakitbek K Kadyraliev; Sabreen Mkalaluh; Jerry Easo; Juergen Ennker; Harald C Eichstaedt; Alexander Weymann Journal: J Thorac Dis Date: 2019-04 Impact factor: 2.895